Finance

Lists
LXEO:NASDAQ
Lexeo Therapeutics Inc
၃.၃၁ US$
+၀.၃၀%
(+၀.၀၁၀၀) 1D
၃.၃၁ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၇, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
၃.၂၇ US$
High
၃.၄၆ US$
Low
၃.၂၂ US$
Mkt. cap
၂၇.၁၇ ကုဋေ
Avg. vol.
၁.၄၂ သန်း
Volume
၁.၁၉ သန်း
52-wk high
၁၀.၉၉ US$
52-wk low
၂.၉၈ US$
EPS
-၁.၁၆ US$
Shares outstanding
၈.၂၁ ကုဋေ
No. of employees
၆၃
Open
၃.၂၇ US$
High
၃.၄၆ US$
Low
၃.၂၂ US$
Mkt. cap
၂၇.၁၇ ကုဋေ
Avg. vol.
၁.၄၂ သန်း
Volume
၁.၁၉ သန်း
52-wk high
၁၀.၉၉ US$
52-wk low
၂.၉၈ US$
EPS
-၁.၁၆ US$
Shares outstanding
၈.၂၁ ကုဋေ
No. of employees
၆၃
News stories
From web sources and news partners
CNBC
CNBC
·
ပြီးခဲ့သည့် ၁ နာရီ
Strange market anomaly is creating a buying opportunity in the Nasdaq 100
Newswire
Newswire
·
ပြီးခဲ့သည့် ၅၇ မိနစ်
FatPipe (NASDAQ: FATN) Refinances Existing Debt and Reduces Borrowing Costs
marketscreener.com
marketscreener.com
·
ပြီးခဲ့သည့် ၁ နာရီ
SMJ International Receives NYSE American Warning Over Delayed Disclosure of Executive Resignations
Seeking Alpha
Seeking Alpha
·
ပြီးခဲ့သည့် ၁၇ မိနစ်
3 things to look out for on Thursday (SP500:)
About Lexeo Therapeutics Inc
CEO-
Employees၆၃
Founded၂၀၁၇
Headquarters-
Sector-
Analyst ratings
Based on 4 analysts giving stock ratings to LXEO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current ၃.၃၁ US$
၂၀.၀၀ US$ (+၅၀၄.၂၃%)
Average
၁၈.၀၀ US$ (+၄၄၃.၈၁%)
Lowest
၁၅.၀၀ US$ (+၃၅၃.၁၇%)
Analyst
Recommendation
Action
Price target
Projected
Date
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
၁၇.၀၀ US$
+၄၁၃.၆%
10/05/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
၁၅.၀၀ US$
+၃၅၃.၂%
09/23/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၂၀.၀၀ US$
+၅၀၄.၂%
09/23/2026
Luca Issi
RBC Capital
Buy
Maintained
၂၀.၀၀ US$
+၅၀၄.၂%
08/12/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
၉.၀၀ US$
+၁၇၁.၉%
06/25/2026
Unknown Analyst
Stifel Nicolaus
Buy
Maintained
၁၇.၀၀ US$
+၄၁၃.၆%
05/12/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
၁၇.၀၀ US$
+၄၁၃.၆%
05/11/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
၁၉.၀၀ US$
+၄၇၄%
03/30/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
၁၀.၀၀ US$
+၂၀၂.၁%
01/13/2026
Christopher Raymond
Raymond James
Buy
Maintained
၂၅.၀၀ US$
+၆၅၅.၃%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၁.၅၇ ကုဋေ
၁.၆၂ ကုဋေ
၁.၅၇ ကုဋေ
၁.၉၀ ကုဋေ
Cost of revenue
၁.၅၇ ကုဋေ
၁.၆၂ ကုဋေ
၁.၅၇ ကုဋေ
၁.၉၀ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၅.၉၅ သန်း
၆.၉၁ သန်း
၆.၆၃ သန်း
၈.၉၉ သန်း
Operating expense
၅.၉၅ သန်း
၆.၉၁ သန်း
၆.၆၃ သန်း
၈.၉၉ သန်း
Total operating expenses
၂.၁၆ ကုဋေ
၂.၃၁ ကုဋေ
၂.၂၃ ကုဋေ
၂.၈၀ ကုဋေ
Operating income
-၂.၁၆ ကုဋေ
-၂.၃၁ ကုဋေ
-၂.၂၃ ကုဋေ
-၂.၈၀ ကုဋေ
Other non operating income
-၉.၀၀ ထောင်
၉.၀၀ ထောင်
-၁.၀၀ ထောင်
-၆.၀၀ ထောင်
EBT including unusual items
-၂.၀၃ ကုဋေ
-၂.၀၉ ကုဋေ
-၂.၀၂ ကုဋေ
-၂.၅၉ ကုဋေ
EBT excluding unusual items
-၂.၀၂ ကုဋေ
-၂.၀၉ ကုဋေ
-၂.၀၂ ကုဋေ
-၂.၅၈ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၀၃ ကုဋေ
-၂.၀၉ ကုဋေ
-၂.၀၂ ကုဋေ
-၂.၅၉ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၃၃
-၀.၂၇
-၀.၂၅
-၀.၃၀
Interest and investment income
၁.၄၆ သန်း
၂.၂၁ သန်း
၂.၁၁ သန်း
၂.၁၉ သန်း
Interest expense
-၂.၂၀ သောင်း
-၂.၀၀ သောင်း
-၁.၇၀ သောင်း
-၁.၄၀ သောင်း
Net interest expenses
၁.၄၃ သန်း
၂.၁၉ သန်း
၂.၁၀ သန်း
၂.၁၈ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၁၅ ကုဋေ
-၂.၃၀ ကုဋေ
-၂.၂၂ ကုဋေ
-၂.၇၉ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ